Stock listing
Actavia Life Sciences, Inc.
Selected listing: RASP · OTC · USD · US
Actavia Life Sciences, Inc. (OTC:RASP), Health Technology. Latest release Jan 3, 2018: Rasna Therapeutics, Inc., Announces Follow Up Phase II Clinical Data…
- Ticker
- OTC:RASP
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Actavia Life Sciences, Inc.
Actavia Life Sciences, Inc. is a public company traded under the ticker RASP in the American market. Actavia focuses on advancing life sciences initiatives and solutions.
Latest news from Actavia Life Sciences, Inc.
Rasna Therapeutics, Inc., Announces Follow Up Phase II Clinical Data Confirming Efficacy of Actinomycin D in Patients with NPM1-Mutated Acute Myeloid Leukemia
January 3, 2018
Rasna Therapeutics Names Dr. Kunwar Shailubhai As New CEO
April 20, 2017
Rasna Therapeutics Announces Upgrade to OTCQX®
April 12, 2017
OTC Markets Group Welcomes Rasna Therapeutics to OTCQX
April 12, 2017
Rasna Therapeutics, Inc. Closes Private Placement of $2 Million
December 27, 2016
Research Actavia Life Sciences, Inc.
Actavia Life Sciences, Inc. company profile
View the public company page for Actavia Life Sciences, Inc. on 6ix.
Actavia Life Sciences, Inc. news
Read company news and market updates connected to Actavia Life Sciences, Inc..
Actavia Life Sciences, Inc. investor events
Find investor webinars, events, and replay context for Actavia Life Sciences, Inc..